125
Participants
Start Date
April 28, 2025
Primary Completion Date
July 15, 2027
Study Completion Date
March 15, 2028
Eganelisib
eganelisib will be administered as monotherapy
Eganelisib in combination with cytarabine
eganelisib will be administered in combination with cytarabine
RECRUITING
Hospital San Pedro de Alcántara, Cáceres
NOT_YET_RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Montefiore Medical Center, New York
RECRUITING
Moffitt Cancer Center, Tampa
RECRUITING
Ohio State University, Columbus
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Hospital Universitari i Politècnic La Fe, Valencia
RECRUITING
Washington University in St Louis, St Louis
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
Anshutz Cancer Pavilion, Aurora
RECRUITING
City of Hope, Duarte
RECRUITING
Dana-Farber Cancer Institute, Boston
Stelexis BioSciences
INDUSTRY